Career history of Jane Robertson
Former positions of Jane Robertson
| Companies | Position | Start | End |
|---|---|---|---|
| REDX PHARMA PLC | Chief Tech/Sci/R&D Officer | 2021-02-28 | 2023-12-31 |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Chief Tech/Sci/R&D Officer | 2017-09-30 | 2021-02-28 |
Kesios Therapeutics Ltd.
 Kesios Therapeutics Ltd. BiotechnologyHealth Technology Kesios Therapeutics Ltd. provides biotechnology services. It develops novel therapeutics for the treatment of multiple myeloma and other cancers where there are significant unmet medical needs. The company was founded by Menotti Ruvo, Laura Tornatore, and Guido Franzoso on July 13, 2012 and is headquartered in Cambridge, the United Kingdom. | Chief Tech/Sci/R&D Officer | 2015-06-30 | 2017-08-31 |
| NUCANA PLC | Chief Tech/Sci/R&D Officer | 2017-01-31 | 2017-08-31 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - | - |
Statistics
International
| United Kingdom | 6 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 6 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| REDX PHARMA PLC | Health Technology |
 | Health Technology |
| NUCANA PLC | Health Technology |
| Private companies | 1 |
|---|---|
Kesios Therapeutics Ltd.
Kesios Therapeutics Ltd. BiotechnologyHealth Technology Kesios Therapeutics Ltd. provides biotechnology services. It develops novel therapeutics for the treatment of multiple myeloma and other cancers where there are significant unmet medical needs. The company was founded by Menotti Ruvo, Laura Tornatore, and Guido Franzoso on July 13, 2012 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Jane Robertson
- Experience
